Hepatocellular carcinoma
ALDH2 · COX2 and 3 more
Related to carcinogen detoxification, inflammation suppression and the cell cycle
Image explaining the principle, from official materials
✓Oral DNA sample✓Genetic analysis✓Company-defined risk levels✓Consultation on symptoms and history
TWO TESTS, TWO QUESTIONS
This page separates two different tests.
Both obtain DNA with an oral swab, but tumor-related risk information and inborn genetic predisposition answer different questions.
01 / Cancer genes15 types
Which tumor-related genes are examined?
From hepatocellular carcinoma to splenic cancer: see the 15 tumor items and representative genes listed on the official page.
See the 15 test items ↓02 / Hereditary diseases6 areasWhich genetic vulnerabilities are examined?
See the heart, joint, skin, metabolic, kidney and liver areas and the representative genes listed on the official page.
See the genes in 6 areas ↓Read them separately first.
Cancer gene tests: tumor risk information based on the company’s criteria; hereditary disease tests: information on genetic predisposition to disease. Neither result replaces confirming or ruling out a current disease.
01 / TUMOR-RELATED GENES
Risk information for 15 tumor types
Example test items and representative genes for 15 tumor types, as listed on the official cancer gene test page.
Skin cancer
NRAS · KIT and 3 more
Related to cell growth signaling and tumor suppressionBladder cancer
PIK3CA · CDKN2A and 3 more
Related to growth factor receptors and cell signalingOsteosarcoma
RB1 · BCL2 and 3 more
Related to tumor suppression, cell proliferation and bone formationGastrointestinal cancer
APC · MLH1 and 3 more
Related to Wnt signaling and cell growthMammary tumor
PIK3CA · ESR1 and 3 more
Related to DNA damage repair and estrogen responseBrain tumor
PTEN · IDH1 and 3 more
Related to growth factor receptors and signaling inhibitionPancreatic cancer
KRAS · CDKN2A and 3 more
Related to the TGF-β pathway and DNA repairBlood cancer
NPM1 · TET2 and 3 more
Related to DNA methylation and immune signalingLymphoma
BCL2 · CDKN2A and 3 more
Related to apoptosis inhibition and immune responseMast cell tumor
KIT · NRAS and 3 more
Related to stem cell growth and hematopoietic regulationLung cancer
EGFR · KRAS and 3 more
Related to epithelial cell growth signaling and tumor suppressionOral cancer
KIT · NRAS and 3 more
Related to melanocyte proliferation and survival signalingThyroid cancer
RE · BRAF and 3 more
Related to thyroid cell growth and differentiation pathwaysSplenic cancer
KDR · PIK3CA and 3 more
Related to angiogenesis, cell growth and tumor suppressionReproduced from the ‘Example test items’ on the official page. ‘RE’ for thyroid cancer is written exactly as shown on the official page; the exact gene name and the panel actually accepted are confirmed before testing.
01Oral epithelial cellsDNA sample prepared with a swab
→02DNA purificationNucleic acid isolation and purification
→03Real-time PCRAnalysis of key genes
→044-level risk ratingClassified by company criteria
→05Result consultationReviewed with symptoms and history
COMPANY RISK SCALE
Tumor results are presented in four levels.
These are the score ranges from the official page. The scores below are the testing lab’s risk classification, not stages of a confirmed tumor diagnosis.
- Good0.0–4.0 points
- Attention4.1–6.0 points
- Caution6.1–8.0 points
- Warning8.1–10.0 points
Tumor risk information ≠ tumor diagnosis
A high risk level does not mean a tumor is present, and a low risk level does not rule out all tumors. Current signs such as lumps, weight loss or changes in appetite are assessed through examination and any necessary additional tests, such as imaging or blood work.
02 / INHERITED CONDITIONS
Genetic predisposition in 6 disease areas
Areas and representative genes presented on the official hereditary disease test page.
Oral swabDNAGene variantsPredisposition by areaSchematic explaining the principle
Heart disease
MYBPC3 · TNNT2 etc.
Risk information related to hypertrophic cardiomyopathy and arrhythmiaJoint disease
COL1A1 · FBN1 etc.
Risk information related to hip dysplasia and articular cartilageSkin disease
SPINK5 · FLG etc.
Related to allergic dermatitis, atopy and the skin barrierMetabolic disease
G6PC · CPT2 etc.
Risk information related to hypoglycemia and energy metabolism disordersKidney disease
PKD1 · COL4A3 etc.
Risk information related to polycystic kidney disease and chronic kidney failureLiver disease
ATP7B · SERPINA1 etc.
Risk information related to copper metabolism disorders and liver fibrosisHOW IT IS ANALYZED
- 01Oral swab collectionObtaining epithelial cells
- 02DNA extraction and purificationPreparing for analysis
- 03Checking related variantsAnalysis with the lab’s primers
- 04Company risk assessmentGood · Attention · Caution · Warning
- 05Result report and consultationChecking family history, species and breed
Genetic predisposition ≠ current disease
Finding a related variant does not mean the disease will necessarily develop. Conversely, the absence of that variant does not eliminate the possibility of all diseases. The applicable species and breeds and the meaning of each variant are confirmed in the actual test documentation.
READING THE RESULT
Check the different parts of the result report.
Risk information for each of 15 tumor types
- Tumor items analyzed and representative genes
- The lab’s 4-level risk rating and score
- Questions about additional tests needed for current symptoms
Genetic predisposition in 6 areas
- Disease areas and variants covered
- What it means for the species and breed
- Questions about family history and long-term care
Start by checking the animal identification, collection date, test name and analysis items on the result report. The testing lab’s interpretation is read together with current clinical information.
Actual kit we have · background removed
SAMPLE & KIT
Check the sample
and kit first.
Check the collection parts, identification details
and storage and shipping conditions for the test you will use.
Concept photo of sample handling
Not an actual Maru clinical scene or a collection from a specific animal.
The parts in our photo are not confirmed as common to all test products.
WITH MARU
From pre-test explanation to post-result consultation.
01Purpose consultationWhat you want to know
and current condition
02Sample preparationKit instructions
and animal identification
03Lab analysisAnalysis method for each test
and quality check
04Understanding resultsMeasured information
and the lab’s interpretation- 05Consultation at Maru
Symptoms and history,
and follow-up care questions
READ MORE WHEN YOU NEED
Expand to learn more.
Depending on your questions, the purpose of the test changes too.
DIFFERENT TESTS, DIFFERENT QUESTIONS
Depending on your questions,
the purpose of the test changes too.
Telomere length, oral microbes, disease-related genes. Because these tests look at different information, the starting point is to understand their purposes and results separately.
Aging-related information
Analyzes telomere length from an oral sample.
View official test information →Oral microbiome information
Looks at oral microbiome composition and the information needed for care.
View official test information →Gene-related information
Distinguishes tumor-related genes from hereditary diseases.
Compare the two tests ↓Test information as presented by the analysis labs. The actual product, eligible animals and intake conditions are confirmed in a pre-test consultation.
Tumor-related information and hereditary diseases: understanding their different purposes.
03 / GENETIC ANALYSIS
Tumor-related information and hereditary diseases:
understanding their different purposes.
Both tests deal with genetic information, but they analyze it to answer different questions. Risk ratings should be read together with clinical care that checks whether a disease is currently present.
03-A / TUMOR-RELATED GENES
Cancer gene tests
The official page describes it as a service that analyzes tumor-related genetic information and provides a risk report.
- A DNA sample is prepared from oral epithelial cells.
- DNA is isolated and purified.
- Key genes are analyzed by real-time PCR.
- A report is provided with the company’s “Good · Attention · Caution · Warning” levels.
When reading the report
Check the test items, target animals and the meaning of each risk level. A high risk level does not mean a confirmed tumor diagnosis, and a low risk level does not rule out all tumors. Symptoms, examination findings and additional test information are reviewed together.
Basis: DNAGENICS’ description of the test principle and results for the “Banryeoae Cancer Gene Test”. The number of items and product scope are confirmed under the actual order conditions.
03-B / INHERITED CONDITIONS
hereditary disease tests
A service that looks at disease-related gene variants. The official page gives heart, joint, skin, metabolic, kidney and liver areas as examples.
- A DNA sample is obtained with an oral swab.
- DNA is isolated and purified.
- Disease-related gene variants are checked.
- A report is provided with risk levels that the company describes as AI-based.
When reading the report
Check which items apply to the species and breed and what each variant means. Genetic risk information does not mean the disease is currently present. Family history and the actual condition are reviewed together to prepare questions for follow-up consultation.
Basis: DNAGENICS’ description of the test principle and areas for the “Banryeoae Hereditary Disease Test”. The AI and risk interpretation are the company’s descriptions; this does not mean we have independently verified diagnostic accuracy.
See the actual kit and check how to prepare for collection.
THE SAMPLE KIT
See the actual kit
and check how to prepare for collection.
The sample and kit used may differ for each test. The collection parts, identification details, and storage and shipping conditions are checked against the instructions for the kit actually used.
We do not infer reagent components or the order of use from the containers in the photo. Preparation related to food, medication and oral care is also explained according to each test’s guidelines.
From explanation before the test to consultation after the results.
WITH MARU
From explanation before the test
to consultation after the results.
- Organize what you want to know.
We review the animal’s basic information, symptoms, family history, medical records and the purpose of the test together.
- Check the test conditions.
The product and items to be used, costs, expected turnaround and re-collection conditions are confirmed in the pre-test information.
- Match the sample and the request information.
We follow the actual kit’s instructions and make sure the animal’s identification matches the request form.
- Receive the lab’s analysis results.
An explanation is prepared based on the result report, after checking sample quality and analysis conditions.
- Interpret together with clinical information.
In the veterinary consultation, we discuss what the results mean and any questions about further care or observation.
Measured values and interpretation: look at both together.
READING YOUR REPORT
Measured values and interpretation:
look at both together.
Check first
- Animal identification and collection date
- Test name · items · analysis method
- Units and reference criteria
Questions to ask in the consultation
- What values were actually measured?
- What do the company’s interpretations mean, and what are their limits?
- How do they relate to current symptoms and history?
For follow-up tests, we also check whether results can be compared with previous ones under the same conditions. Recording changes in values, changes in daily life and clinical progress separately makes explanations more specific.
Before testing: frequently asked questions.
QUESTIONS & ANSWERS
Before testing:
frequently asked questions.
Should my pet have both the cancer gene and hereditary disease tests?+
Each test has a different purpose. We first discuss the animal’s condition, what you want to know and which items actually apply.
If it is an oral sample, is the preparation the same?+
Sample types and kit instructions may differ. Collection, storage and shipping conditions are confirmed according to the instructions for that test.
If the risk level is high, does that mean the disease has developed?+
A risk level is not a confirmed diagnosis. It must be interpreted together with actual symptoms and examination and test findings.
If there is genetic risk information, will the disease definitely develop?+
Genetic information and actual disease onset are not the same thing. The items covered, variants, species, breed, family history and current condition are reviewed together.
How can I find out the cost and turnaround time?+
These are confirmed before testing, based on the actual test ordered and its conditions. This guide does not promise any specific price or timeframe.
Sources for this guide.
INFORMATION SOURCES
Sources for this guide.
DNAGENICS’ official service descriptions have been reorganized to fit the reading flow of the Maru website. The company’s explanations of analysis and interpretation are kept distinct from Maru’s clinical consultation guidance.
- Banryeoae Cancer Gene Test — analysis process and risk levels
- Banryeoae Hereditary Disease Test — variant analysis and result explanation
Source: DNAGENICS official website (dnagenics.co.kr) · checked October 15, 2026. This is not a confirmed list of all products, prices and operating conditions currently accepted by the hospital.